share_log

Canaccord Genuity Maintains Buy on Ventyx Biosciences, Lowers Price Target to $16

Canaccord Genuity Maintains Buy on Ventyx Biosciences, Lowers Price Target to $16

Canaccord Genuity維持對Ventyx Biosciences的買入,將目標股價下調至16美元
Moomoo 24/7 ·  03/11 12:54

Canaccord Genuity analyst Edward Nash maintains Ventyx Biosciences (NASDAQ:VTYX) with a Buy and lowers the price target from $20 to $16.

Canaccord Genuity分析師愛德華·納什維持Ventyx Biosciences(納斯達克股票代碼:VTYX)的買入並將目標股價從20美元下調至16美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論